“I am amazed that I am being personally attacked in a way that sincerely distracts my energy and energy from all the teams we work together to deliver, and therefore reduces our chances or the speed with which we try to help humanity and the country resolve and take. address this issue, “Slaoui said on the podcast, released on Friday.
Michael Caputo, assistant secretary of public affairs at HHS and host of the podcast, began inviting listeners to “enjoy my learning curve as much as I like it.”
“I came to this job without a really deep knowledge of health care,” Caputo added.
Then Caputo asked Slaoui about his career and his appointment as head of Operation Warp Speed. “And since this is the Trump administration, you do not realize it, I guess, maybe when you were offered the job, but part of the deal is that you go ahead and you set a goal on your back, right?”
“Yes. Honestly, I think I was naive when I made the decision,” said Slaoui, who spent 30 years at the pharmaceutical giant GlaxoSmithKline, including as chairman of Global Vaccines. After leaving Glaxo, Slaoui has worked with the European venture capital company Medicxi and been a board member of, among others, vaccine developers Moderna, Intellia Therapeutics, the International AIDS Vaccine Initiative, the Swiss biotechnology and chemicals company Lonza Group.
“I thought the press was particularly informative, but I was [am] now convinced in fact that the press has only one goal, which is to shape opinions and distort information in a way that allows it [them] to formulate an opinion, “added Slaoui.” And I find that unethical, extremely disappointing. And I really hope that society will push to change it back to more normality. “
However, Caputo and Slaoui said they rely on media reports.
“It is much, much harder to help someone who is already ill because they are so, as you can read in the newspapers or listen to the media, the manifestations of this disease are many, many different diseases because they depend on your health status to begin with,” in Slaoui.
Caputo asked for reports that Slaoui, who has held shares in companies funded by the government effort he now leads, can make money on the companies he is now able to promote. Federal employees are generally required to dispose of any holdings they may be able to regulate or influence.
“I’m convinced the reporters do not want a vaccine, sir,” Caputo said. Still, he said stories appear “from reporters who have a hard time counting changes, who are trying to count your wealth, who do not recognize the fact that you have accepted huge losses financially to take this job that pays you $ 1, that keeps you away from your family, who keep you up all day. “
Slaoui stated that he continues to refuse to sell his shares in Glaxo.
“Any valuation of everything I own that has something to do with Covid, which are my GlaxoSmithKline shares, all the values at the end of my assignment will look like – if it has increased value with it – I will sell these shares, and I will provide the incremental value to the NIH for research, ”said Slaoui.